This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for COMIRNATY ® JN.1 ▼ (Bretovameran) COVID-19 mRNA vaccine, COMIRNATY® Omicron XBB.1.5▼ (raxtozinameran) COVID-19 mRNA Vaccine, COMIRNATY® Original/Omicron BA.4-5▼(tozinameran / famtozinameran) COVID-19 mRNA Vaccine, and COMIRNATY®▼ (tozinameran) COVID-19 mRNA Vaccine,  Great Britain (GB) 
Prescribing Information (PI) for COMIRNATY ® JN.1 ▼ (Bretovameran) COVID-19 mRNA vaccine, COMIRNATY® Omicron XBB.1.5▼(raxtozinameran) COVID-19 mRNA Vaccine, COMIRNATY® Original/Omicron BA.4-5▼(tozinameran / famtozinameran) COVID-19 mRNA Vaccine, and COMIRNATY®▼ (tozinameran) COVID-19 mRNA Vaccine,  Northern Ireland (NI)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Comirnaty JN.1 30 micrograms/dose dispersion  for injection COVID-19 mRNA Vaccine ready for use 12+ years - PI for GB

    Comirnaty JN.1 10 micrograms/dose dispersion  for injection, single dose vial COVID-19 mRNA Vaccine ready for use childrne 5 to 11 years - PI for GB

    Comirnaty JN.1 3 micrograms/dose concentrate for  dispersion for injection, 3-dose vial COVID-19 mRNA Vaccine dilute before use 6 months to 4 years - PI for GB

    COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection multi-dose vial, COVID-19 mRNA Vaccine ready for use, 12+ years - PI for GB

    COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine ready for use, children 5 to 11 years - PI for GB

    COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine dilute before use, 6 months to 4 years - PI for GB

    COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine ready for use, 12+ years - PI for GB
  • COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine dilute before use, children 5 to 11 years - PI for GB

    COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine dilute before use, 6 months to 4 years -  PI for GB

Northern Ireland

  • Comirnaty JN.1 30 micrograms/dose concentrate for  dispersion for injection, 3-dose vial COVID-19 mRNA Vaccine dilute before use 6 months to 4 years - PI for NI

    Comirnaty JN.1 10 micrograms/dose dispersion  for injection, single dose vial COVID-19 mRNA Vaccine ready for use children 5 to 11 years - PI for NI

    Comirnaty JN.1 3 micrograms/dose concentrate for  dispersion for injection, 3-dose vial COVID-19 mRNA Vaccine dilute before use 6 months to 4 years - PI for GB
  • COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection multi-dose vial, COVID-19 mRNA Vaccine ready for use, 12+ years - PI for NI
  • COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine ready for use, children 5 to 11 years - PI for NI
  • COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine dilute before use, 6 months to 4 years - PI for NI

    COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine ready for use, 12 + years - PI for NI

    COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine dilute before use, children 5 to 11 years - PI for NI

    COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine dilute before use, 6 months to 4 years - PI – NI

Comirnaty JN.1 30 micrograms/dose dispersion  for injection COVID-19 mRNA Vaccine ready for use 12+ years - PI for GB

Comirnaty JN.1 10 micrograms/dose dispersion  for injection, single dose vial COVID-19 mRNA Vaccine ready for use children 5 to 11 years - PI for GB

Comirnaty JN.1 3 micrograms/dose concentrate for  dispersion for injection, 3-dose vial COVID-19 mRNA Vaccine dilute before use 6 months to 4 years - PI for GB

COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection multi-dose vial, COVID-19 mRNA Vaccine ready for use, 12+ years - PI for GB

COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine ready for use, children 5 to 11 years - PI for GB

COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine dilute before use, 6 months to 4 years - PI for GB

COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine ready for use, 12+ years - PI for GB

COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine dilute before use, children 5 to 11 years - PI for GB

COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine dilute before use, 6 months to 4 years -  PI for GB 

Comirnaty JN.1 30 micrograms/dose dispersion  for injection COVID-19 mRNA Vaccine ready for use 12+ years - PI for NI

Comirnaty JN.1 10 micrograms/dose dispersion  for injection, single dose vial COVID-19 mRNA Vaccine ready for use childrne 5 to 11 years - PI for NI

Comirnaty JN.1 3 micrograms/dose concentrate for  dispersion for injection, 3-dose vial COVID-19 mRNA Vaccine dilute before use 6 months to 4 years - PI for GB

COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection multi-dose vial, COVID-19 mRNA Vaccine ready for use, 12+ years - PI for NI

COMIRNATY Omicron XBB.1.5 10 micrograms/dose dispersion for injection, COVID-19 mRNA Vaccine ready for use, children 5 to 11 years - PI for NI

COMIRNATY Omicron XBB.1.5 3 micrograms/dose concentrate for dispersion for injection, COVID-19 mRNA Vaccine dilute before use, 6 months to 4 years - PI for NI

 

COMIRNATY Original/Omicron BA.4-5 (tozinameran / famtozinameran) (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine ready for use, 12 + years - PI for NI 

COMIRNATY (tozinameran) 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine dilute before use, children 5 to 11 years - PI for NI

COMIRNATY (tozinameran) 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine dilute before use, 6 months to 4 years - PI – NI

PP-CMR-GBR-0654 August 2024